Clinical trial
SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With…
NCT00043784 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00043784 |
|---|---|
| Title | SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes |
| Official title | A Prospective, Randomized, Open-Label, Multicenter Study in Patients Presenting With Acute Coronary Syndromes (ACS) |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Unstable Angina, Myocardial Infarction, Myocardial Ischemia |
| Intervention type | Drug |
| Interventions | enoxaparin |
| Enrollment | 8,000 |
| Start date | Aug 1, 2001 |
| Primary completion | Feb 1, 2005 |
| First posted | Aug 15, 2002 |
| Last update posted | Sep 16, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: